Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
| Item number | Size | Datasheet | Manual | SDS | Delivery time | Quantity | Price |
|---|---|---|---|---|---|---|---|
| TGM-T21119-25mg | 25 mg |
7 - 10 business days* |
2,117.00€
|
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Description: Cevimeline, a parasympathomimetic and muscarinic agonist, affects M1 and M3... more
Product information "Cevimeline"
Description: Cevimeline, a parasympathomimetic and muscarinic agonist, affects M1 and M3 receptors. Cevimeline has been shown to treat dry mouth and Sj gren's syndrome. It is also used to reduce Xerostomia symptoms and increase salivary flow in head and neck cancer survivors after radiotherapy. Target: Others. Smiles: C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1. References: Barbe AG. Long-term Use of the Sialogogue Medications Pilocarpine and Cevimeline Can Reduce Xerostomia Symptoms and Increase Salivary Flow in Head and Neck Cancer Survivors After Radiotherapy. J Evid Based Dent Pract. 2017 Sep,17(3):268-270. doi: 10.1016/j.jebdp.2017.06.013. Epub 2017 Jul 3. PubMed PMID: 28865825.
| Keywords: | AF-102B, FKS 508, SNI 2011, HSDB 7286 |
| Supplier: | TargetMol |
| Supplier-Nr: | T21119 |
Properties
| Application: | Targets muscarinic acetylcholine receptor M3 (CHRM3) |
| MW: | 199.31 D |
| Formula: | C10H17NOS |
Database Information
| CAS : | 107233-08-9| Matching products |
| KEGG ID : | K04131 | Matching products |
Handling & Safety
| Storage: | +4°C |
| Shipping: | +4°C (International: +4°C) |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed